Knee Cartilage Repair Market Report 2026

The knee cartilage repair market size has grown strongly in recent years. It will grow from $3.1 billion in 2025 to $3.31 billion in 2026 at a compound annual growth rate (CAGR) of 6.7%. The growth in the historic period can be attributed to increasing prevalence of osteoarthritis, rising incidence of knee injuries among athletes, established use of arthroscopic procedures, growing demand for joint preservation techniques, expansion of orthopedic surgical infrastructure.

The knee cartilage repair market size is expected to see strong growth in the next few years. It will grow to $4.16 billion in 2030 at a compound annual growth rate (CAGR) of 5.9%. The growth in the forecast period can be attributed to aging population with cartilage degeneration, increasing adoption of regenerative medicine, rising demand for motion-preserving knee treatments, advancements in biomaterials and implants, growing awareness of early cartilage intervention. Major trends in the forecast period include rising adoption of minimally invasive cartilage repair procedures, growing use of cell-based and regenerative therapies, increasing preference for arthroscopic knee cartilage treatments, expansion of sports injury-related cartilage repair surgeries, improved clinical outcomes with advanced implant materials.

The increasing prevalence of sports-related injuries is anticipated to drive the expansion of the knee cartilage repair market in the coming years. Sports-related injuries are defined as physical damage incurred during athletic or recreational activities, commonly resulting from repetitive strain, overuse, or traumatic events, and often leading to joint discomfort, cartilage deterioration, and restricted mobility. The growth in these injuries is linked to greater sports participation, intensified training routines, and inadequate preventive practices. Knee cartilage repair aids in the recovery process by repairing damaged cartilage, alleviating pain, and facilitating a quicker return to physical activity while reducing the likelihood of long-term joint degeneration. For example, in July 2025, the Australian Institute of Health and Welfare, a national government health statistics organization in Australia, reported that more than 62,100 hospitalizations due to sports-related injuries occurred in Australia during 2023-24, with males accounting for approximately 70% of cases (around 43,800) and females making up nearly 30% (about 18,300). Consequently, the rising occurrence of sports-related injuries is fueling the growth of the knee cartilage repair market.

Major companies in the knee cartilage repair market are focusing on developing innovative products, such as knee cartilage repair implants, to strengthen their competitive position. These implants are medical devices used in orthopedic surgeries to support the repair and regeneration of damaged knee cartilage. For instance, in March 2024, UC Davis Health, a U.S.-based medical center, launched the MISHA Knee System, a resorbable knee cartilage repair implant designed to aid cartilage restoration. The MISHA Knee System stimulates the body’s natural healing process, enabling new cartilage and bone tissue to regenerate and gradually integrate with the implant over time.

In January 2024, Smith & Nephew plc, a UK-based medical equipment company, acquired CartiHeal Ltd. for $180 million. Through this acquisition, Smith & Nephew strengthens its focus on expanding its successful sports medicine segment and advancing its knee repair portfolio, with the goal of improving cartilage repair outcomes. CartiHeal Ltd. is a US-based medical device company that offers innovative knee cartilage repair technology.

Major companies operating in the knee cartilage repair market are Stryker Corporation, B. Braun Melsungen AG, DePuy Synthes, Zimmer Biomet Holdings Inc., Smith & Nephew plc, Arthrex Inc., Integra LifeSciences, Bioventus LLC, MTF Biologics, MiMedx Group Inc., Moximed Inc., Vericel Corporation, Anika Therapeutics Inc., SeaSpine Holdings Corporation, LifeNet Health, ConforMIS Inc., Geistlich Pharma AG, BioPoly LLC, Regen Lab SA, Octane Medical Group Inc., Orthocell Limited, Episurf Medical AB.

North America was the largest region in the knee cartilage repair market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the knee cartilage repair market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the knee cartilage repair market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have moderately impacted the knee cartilage repair market by increasing the cost of imported implants, arthroscopic instruments, and regenerative therapy components. Device segments such as cartilage implants, bone grafts, and stem cell-based devices are most affected, particularly in North America and Europe due to reliance on global orthopedic supply chains. Hospitals and ambulatory surgical centers face higher procurement and procedural costs, which may influence treatment pricing. However, tariffs have also encouraged localized manufacturing, supplier diversification, and long-term strengthening of regional orthopedic device ecosystems.

The knee cartilage repair market research report is one of a series of new reports that provides knee cartilage repair market statistics, including knee cartilage repair industry global market size, regional shares, competitors with a knee cartilage repair market share, detailed knee cartilage repair market segments, market trends and opportunities, and any further data you may need to thrive in the knee cartilage repair industry. This knee cartilage repair market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Knee cartilage repair refers to medical interventions aimed at treating damage to the cartilage within the knee joint. This cartilage is a smooth, resilient tissue that allows the bones to glide easily against one another without friction. When the cartilage is compromised - whether from injury, degeneration such as osteoarthritis, or other causes - it can lead to symptoms including pain, stiffness, swelling, and reduced range of motion.

The primary device types used in knee cartilage repair include implants, osteotomy, bone grafts, arthroscopy, resurfacing, arthrodesis, and others. Implants are synthetic components surgically inserted into the knee joint to restore or replace damaged cartilage. These are used in procedures such as arthroscopic chondroplasty, autologous chondrocyte implantation, cell-based cartilage resurfacing, and osteochondral graft transplantation, and are utilized by various end users, particularly hospitals, ambulatory surgical centers, and orthopedic clinics.

The knee cartilage repair market consists of revenues earned by entities by providing services such as stem cell therapy, physical therapy, and rehabilitation services. The market value includes the value of related goods sold by the service provider or included within the service offering. The knee cartilage repair market also includes sales of autologous chondrocyte implantation kits, osteochondral graft transplantation materials, non-steroidal anti-inflammatory medications, and fixation devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.